Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




BD Diagnostics Acquires Dynacon's Lab Systems Division

By LabMedica International staff writers
Posted on 12 Apr 2010
With the acquisition that closed late March 2010, BD Diagnostics gets Dynacon's preanalytical specimen processors, which help increase laboratory efficiency and automate the modern microbiology laboratory.

BD Diagnostics a segment of Becton, Dickinson and Company (Franklin Lakes, NJ, USA) expanded its diagnostics portfolio with the acquisition of Dynacon's (Ontario, Canada) lab systems division for an undisclosed sum. More...
BD Diagnostics obtained preanalytical, microbiology automation platforms including InocuLAB and Innova, which complement its infectious disease testing line.

The Innova system, a versatile, high-throughput specimen processor, helps address laboratories' increasing needs for preanalytical specimen processing automation. These needs have arisen because of labor shortages and/or increasing test volumes. Innova also helps reduce laboratory errors associated with specimen handling. The Innova system accommodates the full range of microbiology specimen containers, streak patterns, protocols, and workflows. The InocuLAB system has been used in clinical labs in North America and Europe routinely for nine years.

"Today's clinical microbiology laboratories face many challenges, chief among them are a shortage of laboratory professionals and an increase in workload," said Philippe Jacon, president, diagnostic systems, BD. "The addition of Dynacon's Lab Systems portfolio demonstrates BD's commitment to providing labs with the tools and products they need to enhance the quality of their tests results, improve turnaround times, and make the most cost-effective use of their resources."

BD Diagnostics is a leader of products and instruments used for diagnosing infectious diseases. The products are used in the clinical market to screen for microbial presence, grow and identify organisms, and test for antibiotic susceptibility.

Related Links:

BD Diagnostics
Becton, Dickinson and Company
Dynacon



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.